Reduction in acute headache medication use among episodic migraine patients in the HALO fremanezumab trial

Authors
Category Primary study
ConferenceNeurological Sciences
Year 2019
This article has no abstract
Epistemonikos ID: 2cf3dae4290a7642bdc4aa593ce68ebf072f3ab7
First added on: Apr 30, 2026